Oncolinx Overview
- Year Founded
-
2014
- Status
-
Out of Business
- Employees
-
2
- Latest Deal Type
-
Out of Business
Oncolinx General Information
Description
Developer of antibody-drug conjugates designed to avoid side effects associated with traditional forms of chemotherapy. The company's conjugates carry an Azonafide cytotoxin attached to an antibody specific to tumor cells and not healthy cells which have the ability to both induce cancer cell death and activate the immune system through immunogenic cell death, enabling medical researchers and oncologists to develop a therapy which is less painful than chemotherapy.
Contact Information
Website
www.oncolinx.comCorporate Office
- 640 Ellicott Street
- Suite 108
- Buffalo, NY 14203
- United States
Corporate Office
- 640 Ellicott Street
- Suite 108
- Buffalo, NY 14203
- United States
Oncolinx Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 8. Out of Business | 14-Oct-2021 | Completed | Out of Business | |||
| 7. Accelerator/Incubator | 27-Oct-2016 | Completed | Generating Revenue | |||
| 6. Grant | 04-Aug-2016 | Completed | Generating Revenue | |||
| 5. Angel (individual) | 01-Jul-2016 | Completed | Generating Revenue | |||
| 4. Accelerator/Incubator | 01-Jan-2016 | Completed | Generating Revenue | |||
| 3. Angel (individual) | 30-Dec-2014 | Completed | Generating Revenue | |||
| 2. Grant | 21-Jul-2014 | $250K | Completed | Generating Revenue | ||
| 1. Accelerator/Incubator | 24-Jun-2014 | Completed | Generating Revenue |
Oncolinx Comparisons
Industry
Financing
Details
Oncolinx Competitors (36)
One of Oncolinx’s 36 competitors is Immunophotonics, a Private Equity-Backed company based in Saint Louis, MO.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Immunophotonics | Private Equity-Backed | Saint Louis, MO | ||||
| Kite Pharma | Formerly VC-backed | Santa Monica, CA | ||||
| Onconova Therapeutics | Formerly VC-backed | Newtown, PA | ||||
| Meditope Biosciences | Formerly VC-backed | Pasadena, CA | ||||
| XNK Therapeutics | Formerly VC-backed | Huddinge, Sweden |
Oncolinx Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Oncolinx Patents
Oncolinx Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2023196958-A2 | Tumor and cancer targeting compounds | Inactive | 07-Apr-2022 | ||
| WO-2023196958-A3 | Tumor and cancer targeting compounds | Inactive | 07-Apr-2022 | ||
| WO-2022182395-A1 | Small molecule inhibitors of stat3 n-terminal domain and methods of use | Inactive | 26-Feb-2021 | A61K31/498 |
Oncolinx Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Oncolinx FAQs
-
When was Oncolinx founded?
Oncolinx was founded in 2014.
-
Where is Oncolinx headquartered?
Oncolinx is headquartered in Buffalo, NY.
-
What is the size of Oncolinx?
Oncolinx has 2 total employees.
-
What industry is Oncolinx in?
Oncolinx’s primary industry is Drug Discovery.
-
Is Oncolinx a private or public company?
Oncolinx is a Private company.
-
What is Oncolinx’s current revenue?
The current revenue for Oncolinx is .
-
How much funding has Oncolinx raised over time?
Oncolinx has raised $1.41M.
-
Who are Oncolinx’s competitors?
Immunophotonics, Kite Pharma, Onconova Therapeutics, Meditope Biosciences, and XNK Therapeutics are some of the 36 competitors of Oncolinx.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
